Strategies to keep drug discovery research alive in the US despite funding cuts

In the face of US federal funding cuts, biomedical researchers propose strategies for continued progress in drug discovery. Publishing in Trends in Pharmacological Sciences, their recommendations include harnessing AI and computational analyses in early-stage research, diversifying funding sources, pursuing earlier licensing and commercialization, and fostering international collaborations.

This post was originally published on this site